Home
NBY
NBY News

Latest NovaBay Pharmaceuticals Inc. (NBY) News on September 14, 2025

GlobeNewswire

25 days ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Business Wire

6 months ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Business Wire

8 months ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why

Zacks

9 months ago

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Business Wire

9 months ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Business Wire

9 months ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Business Wire

10 months ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Business Wire

10 months ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand

Business Wire

10 months ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Business Wire

10 months ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Business Wire

a year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

PR Newswire

a year ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Business Wire

a year ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Business Wire

a year ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Business Wire

a year ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Business Wire

a year ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Business Wire

a year ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Business Wire

a year ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Business Wire

a year ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Business Wire

a year ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Business Wire

a year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Business Wire

a year ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Start Proud Opens the Market

CNW Group

a year ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Associated Press Finance

a year ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Business Wire

a year ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

Investor's Business Daily

a year ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary

Yahoo Finance Video

a year ago

May jobs reports signals Fed's soft landing: US Labor Secretary

Notification of major holding in Kindred Group plc

PR Newswire

a year ago

Notification of major holding in Kindred Group plc

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

Form 8.3 - DS Smith plc

Business Wire

a year ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

Business Wire

a year ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript

Business Wire

a year ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

Business Wire

a year ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

Business Wire

a year ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

Business Wire

a year ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Business Wire

a year ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Business Wire

a year ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Business Wire

a year ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call

Business Wire

a year ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Business Wire

a year ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Business Wire

a year ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals

GlobeNewswire

2 years ago

NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals

Business Wire

2 years ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

ClearOne to Showcase Conference and Collaboration Solutions for Every Size of Meeting Space at ISE 2024

Business Wire

2 years ago

ClearOne to Showcase Conference and Collaboration Solutions for Every Size of Meeting Space at ISE 2024

Inspire Veterinary Partners (NASDAQ: IVP): Empowering Veterinary Professionals Through Its Employee-Oriented Ownership Model

ACCESSWIRE

2 years ago

Inspire Veterinary Partners (NASDAQ: IVP): Empowering Veterinary Professionals Through Its Employee-Oriented Ownership Model

Super League Aligns Team to Super Serve Rapidly Expanding Roster of Partners Committing Sizable Budgets to the 3D Web

GlobeNewswire

2 years ago

Super League Aligns Team to Super Serve Rapidly Expanding Roster of Partners Committing Sizable Budgets to the 3D Web

Venus Concept Inc. Announces Review of Strategic Alternatives

GlobeNewswire

2 years ago

Venus Concept Inc. Announces Review of Strategic Alternatives

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

GlobeNewswire

2 years ago

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

CalciMedica Announces Private Placement of up to Approximately $55 Million

PR Newswire

2 years ago

CalciMedica Announces Private Placement of up to Approximately $55 Million

WISeKey and Xapo Bank Join Forces to Showcase WISe.ART Digital and Physical Art Exhibition in Gibraltar

GlobeNewswire

2 years ago

WISeKey and Xapo Bank Join Forces to Showcase WISe.ART Digital and Physical Art Exhibition in Gibraltar

SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable

GlobeNewswire

2 years ago

SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable

WISeKey’s Subsidiary, WISe.ART, a Digital Assets Leading Platform in the Field of Digital Art and Luxury Collectibles,

GlobeNewswire

2 years ago

WISeKey’s Subsidiary, WISe.ART, a Digital Assets Leading Platform in the Field of Digital Art and Luxury Collectibles,

WISeKey International Holding Ltd and The Hashgraph Association Unveil Groundbreaking Tokenization Initiative for WISe.Art during Davos 2024

GlobeNewswire

2 years ago

WISeKey International Holding Ltd and The Hashgraph Association Unveil Groundbreaking Tokenization Initiative for WISe.Art during Davos 2024

DatChat, Inc. Announces Pricing of $1.8 Million Underwritten Public Offering of Common Stock

GlobeNewswire

2 years ago

DatChat, Inc. Announces Pricing of $1.8 Million Underwritten Public Offering of Common Stock

Super League Announces Preliminary Record Fourth Quarter Revenue of Approximately $9.4 Million; an Increase of 32% Year-over-Year

GlobeNewswire

2 years ago

Super League Announces Preliminary Record Fourth Quarter Revenue of Approximately $9.4 Million; an Increase of 32% Year-over-Year

Associated Press Finance

2 years ago

Greenlane: Q3 Earnings Snapshot

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network

ACCESSWIRE

2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network

GlobeNewswire

2 years ago

AirNet Announces Receipt of Deficiency Letter from Nasdaq

Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer

GlobeNewswire

2 years ago

Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer

ACCESSWIRE

2 years ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD

GlobeNewswire

2 years ago

Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD

Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy

GlobeNewswire

2 years ago

Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy

Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates

GlobeNewswire

2 years ago

Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates

Genasys to Present at Leading Investor Conferences

GlobeNewswire

2 years ago

Genasys to Present at Leading Investor Conferences

Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024

PR Newswire

2 years ago

Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024

Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 years ago

Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference

NeuroBo to Participate in Industry and Investor Conferences in January

PR Newswire

2 years ago

NeuroBo to Participate in Industry and Investor Conferences in January

Estimating The Intrinsic Value Of AirNet Technology Inc. (NASDAQ:ANTE)

Simply Wall St.

2 years ago

Estimating The Intrinsic Value Of AirNet Technology Inc. (NASDAQ:ANTE)

Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia

GlobeNewswire

2 years ago

Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia

Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023

ACCESSWIRE

2 years ago

Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

GlobeNewswire

2 years ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

BTC Digital Ltd. Announces Entry into Share Subscription Agreements in Connection with Private Placement of Ordinary Shares

PR Newswire

2 years ago

BTC Digital Ltd. Announces Entry into Share Subscription Agreements in Connection with Private Placement of Ordinary Shares

Medigus: Charging Robotics Targets the $1.8 Billion Automated Parking Market for EV Wireless Charging Solution

GlobeNewswire

2 years ago

Medigus: Charging Robotics Targets the $1.8 Billion Automated Parking Market for EV Wireless Charging Solution

GlobeNewswire

2 years ago

AirNet Technology Inc. Announces Unaudited Financial Results for the First Half of 2023

Carnival (CCL) Reports Q4 Loss, Tops Revenue Estimates

Zacks

2 years ago

Carnival (CCL) Reports Q4 Loss, Tops Revenue Estimates

The Returns On Capital At Tantech Holdings (NASDAQ:TANH) Don't Inspire Confidence

Simply Wall St.

2 years ago

The Returns On Capital At Tantech Holdings (NASDAQ:TANH) Don't Inspire Confidence

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

GlobeNewswire

2 years ago

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

ACCESSWIRE

2 years ago

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

Cosmos Health Announces Open Market Stock Purchases by the CEO

ACCESSWIRE

2 years ago

Cosmos Health Announces Open Market Stock Purchases by the CEO

Amtech (NASDAQ:ASYS) Reports Weak Q4

StockStory

2 years ago

Amtech (NASDAQ:ASYS) Reports Weak Q4

Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing

GlobeNewswire

2 years ago

Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing

BTCS Inc. (BTCS) is a Great Momentum Stock: Should You Buy?

Zacks

2 years ago

BTCS Inc. (BTCS) is a Great Momentum Stock: Should You Buy?

Lisata Therapeutics Announces Completion of Enrollment in Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal Adenocarcinoma

GlobeNewswire

2 years ago

Lisata Therapeutics Announces Completion of Enrollment in Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal Adenocarcinoma

Has FlexShopper (FPAY) Outpaced Other Finance Stocks This Year?

Zacks

2 years ago

Has FlexShopper (FPAY) Outpaced Other Finance Stocks This Year?

CNW Group

2 years ago

Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management

Business Wire

2 years ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

GENERATIONS BANCORP NY, INC. APPOINTS ANGELA KREZMER AS PRESIDENT & CEO

PR Newswire

2 years ago

GENERATIONS BANCORP NY, INC. APPOINTS ANGELA KREZMER AS PRESIDENT & CEO

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

11 Most Volatile Stocks Under $5 For Day Trading

Insider Monkey

2 years ago

11 Most Volatile Stocks Under $5 For Day Trading

GlobeNewswire

2 years ago

AirNet Announces Receipt of Minimum Bid Price Notice from Nasdaq

Lisata Therapeutics to Present at NobleCon19 Investor Conference

GlobeNewswire

2 years ago

Lisata Therapeutics to Present at NobleCon19 Investor Conference

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

2 years ago

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Greenlane Announces Receipt of Nasdaq Listing Deficiency Notice

ACCESSWIRE

2 years ago

Greenlane Announces Receipt of Nasdaq Listing Deficiency Notice

Here's What To Make Of Nisun International Enterprise Development Group's (NASDAQ:NISN) Decelerating Rates Of Return

Simply Wall St.

2 years ago

Here's What To Make Of Nisun International Enterprise Development Group's (NASDAQ:NISN) Decelerating Rates Of Return

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

GlobeNewswire

2 years ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency

GlobeNewswire

2 years ago

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency

Share on Social Networks: